We’re seeing what happens when the FDA loses credibility

Washington Post

21 July 2021 - It’s not just politicians who are worried about the decision to approve a new Alzheimer’s drug.

Senators Bill Cassidy and Elizabeth Warren don’t agree on much. Yet both are troubled by the U.S. FDA’s approval of the Alzheimer’s disease drug Aduhelm. 

In a recent letter, they took a slap at the drug, worrying that tens of billions of dollars would be spent on “just one product with limited evidence of clinical efficacy thus far.”

Read Washington Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in: